The molecular landscape of premenopausal breast cancer

INTRODUCTION: Breast cancer in premenopausal women (preM) is frequently associated with worse prognosis compared to that in postmenopausal women (postM), and there is evidence that preM estrogen receptor-positive (ER+) tumors may respond poorly to endocrine therapy. There is, however, a paucity of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Serena, Hartmaier, Ryan J., McGuire, Kandace P., Puhalla, Shannon L., Luthra, Soumya, Chandran, Uma R., Ma, Tianzhou, Bhargava, Rohit, Modugno, Francesmary, Davidson, Nancy E., Benz, Steve, Lee, Adrian V., Tseng, George C., Oesterreich, Steffi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531812/
https://www.ncbi.nlm.nih.gov/pubmed/26251034
http://dx.doi.org/10.1186/s13058-015-0618-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531812/
https://www.ncbi.nlm.nih.gov/pubmed/26251034
http://dx.doi.org/10.1186/s13058-015-0618-8

Ejemplares similares